Gallium follicular lymphoma
WebApr 9, 2024 · A minority of patients with follicular lymphoma (FL) undergo histological transformation (HT). This retrospective analysis of 549 patients from the phase 3 GALLIUM study (NCT01332968) assessed the relationship between maximum standardized uptake value (SUVmax) at baseline on positron emission tomography (PET) and HT risk. WebOct 5, 2024 · A total of 1202 patients with follicular lymphoma that was diagnosed by investigators were enrolled (601 patients in the group that …
Gallium follicular lymphoma
Did you know?
WebAug 1, 2024 · Complete metabolic response (CMR) on PET/CT was the sole independent predictor of overall survival in the PET substudy of the phase III GALLIUM trial ([NCT01332968][1]) in first-line treatment of high-tumor-burden follicular lymphoma. The aim of this analysis was to further investigate the outcome of patients not achieving … WebJun 20, 2024 · June 11, 2024—Vienna, Austria—A final analysis of the GALLIUM trial have confirmed the role of obinutuzumab-chemotherapy as a standard-of-care option for advanced, previously untreated follicular lymphoma. Findings were presented at the European Hematology Association Hybrid Congress, which took place here and online …
WebWe evaluated early disease progression and its impact on overall survival (OS) in previously untreated follicular lymphoma patients in GALLIUM (clinicaltrials.gov … WebFeb 16, 2024 · Answer: We consider bendamustine and rituximab (BR) as our preferred regimen as first-line therapy for a symptomatic patient with follicular lymphoma. To support our preference, we will first discuss the …
WebDec 4, 2024 · Patient 3: A 67-year-old woman was treated in 2014 for follicular lymphoma grade 1, Ann Arbor stage IV, with 6 cycles of bendamustine and rituximab. She … WebApproval was based on a multicenter, open-label, randomized phase 3 trial (GALLIUM) for patients with previously untreated non-Hodgkin lymphoma, including 1202 patients with FL.
WebJul 28, 2024 · Chemoimmunotherapy with rituximab (R-chemo) or obinutuzumab (G-chemo) is standard of care for patients with previously untreated symptomatic or high-tumor-burden follicular lymphoma. Median progression-free survival (PFS) with R-chemo plus R maintenance exceeds 10 years, and G-chemo plus G maintenance improves PFS …
WebIn GALLIUM (n = 1004; 127 with and 877 without POD24), FLEX increased the intergroup (low-risk/high-risk) difference in 2-year and 3-year PFS rates and demonstrated superior intergroup differences in 2-year and 3-year OS rates … red latex tubing for saleWebThe combination of the anti-CD20 monoclonal antibody rituximab with chemotherapy has significantly improved outcomes in patients with newly diagnosed follicular lymphoma. 1-4 The use of... red lathamWebApr 4, 2024 · Among patients with an EOI CR by CT in GALLIUM and GOYA, 2.8% and 4.1%, respectively, had a BMB-altered response. These results suggest that postinduction BMB histology has minimal impact on radiographically (CT)-defined responses in both FL and DLBCL patients. richard d mcateer easton paWebJul 9, 2024 · Carla Casulo, MD: The GALLIUM study randomized patients with follicular lymphoma to obinutuzumab-containing chemotherapy or rituximab-containing chemotherapy. Obinutuzumab is an anti-CD20... richard d mcanultyWebMar 17, 2024 · Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression . Haematologica . 2024 ; 105 ( 5 ): 1465 . Google Scholar Crossref PubMed 4. Luminari red lauanWebSep 16, 2024 · Backgrounds: GALLIUM is a global phase III study that demonstrated significant improvements in progression-free survival (PFS) for obinutuzumab plus chemotherapy (G-chemo) vs. rituximab plus chemotherapy (R-chemo) in previously untreated patients with follicular lymphoma (FL). red latex stickerWebApr 16, 2024 · GALLIUM Trial: Follicular Lymphoma. John M. Burke, MD: The choice between obinutuzumab and rituximab is an interesting one. In my practice, I choose … red latin dress